Brigatinib Before Brain Irradiation Trial (B3i Trial): A Phase II Trial of Brigatinib Alone for Brain Metastases from ALK+ Lung Cancer
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
City of Hope Cancer Center
Mayo Clinic, Rochester
University of Colorado Hospital
Study ID
Protocol Number: 19-2862
More information available at ClinicalTrials.gov: NCT04634110
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers